Merck sues the US government to stop negotiating the price of Medicare drugs

NEW YORK, June 6 (Reuters) – Merck & Co (MRK.N) sued the U.S. government on Tuesday, seeking to halt the Medicare drug price negotiation program contained in the Inflation Reduction Act (IRA), which he says violates the Fifth and First Amendments to the United States Constitution. This is the first attempt by a drugmaker to defy the law, which the pharmaceutical industry says will result in lost profits forcing them to pull out of developing innovative new treatments. Americans pay more for prescription medicines than any other country. The Biden…

Read More

Price out of health: how expensive drugs are putting lives at risk

In Bulgaria, 19% of respondents in a recent survey revealed that they cannot afford all the medicines they need. In this latest episode of Smart Health, we find out how the EU sets out to cut costs to help those most in need. Mariana Alexandrova, 53, lives in Sofia, the capital of Bulgaria. She has type 2 diabetes and her heart is very fragile. “I take three types of medicines for the heart, two types for diabetes and about four other types of medicines for other diseases,” he told Euronews.…

Read More